Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Cross-Sectional Study

Analytical Interference with Contrast Agents in Genetic Test Result for Thrombophilia

Author(s): Ozlem Oz* and Ataman Gonel

Volume 21, Issue 4, 2024

Published on: 27 January, 2023

Page: [823 - 827] Pages: 5

DOI: 10.2174/1570180820666230105164237

Price: $65

Abstract

Background: Diagnostic and therapeutic drugs can change the laboratory results of patients by interfering with the measurement method and may compromise diagnostic efficiency. Incorrect results in biochemical tests used in the clinical follow-up of a patient during treatment may lead to improper applications. Unfortunately, this situation leads the clinician to misdiagnosis.

Objective: The focus of this cross-sectional study is to investigate the effects of three different radiopaque substances commonly used in the clinic on thrombophilia molecular genetic results.

Methods: Peripheric blood samples from three patients whose thrombophilia panel was planned to be studied were included. Blood samples that did not contain any radiopaque material or distilled water were studied as a control group. Except for the control group four different study groups were formed by adding distilled water, Ioversol, Fluorescein Na, and Gadobutrol. This radiopaque substances were added at a ratio of 1/10 to each patient's blood sample before DNA isolation. Prothrombin G20210A, MTHFR C677T, MTHFR A1298C, Factor V Leiden G169A and PAI-1 4G/5G mutations were studied by Real Time-PCR method.

Results: There was no change at the thrombophilia panel results in the study groups compared with the control groups in patients 1 and 3. In patient 2, there was no change when the result of MTHFR C677T was compared to the results of blood+DW and blood+Gadobutrol. But there were alterations in blood+Ioversol and blood+Fluorescein Na samples; the result of heterozygous MTHFR C677T was observed to change to homozygous MTHFR C677T.

Conclusion: This study showed that Ioversol and Fluorescein Na could change the results of the thrombophilia genetic analysis for MTHFR C677T mutation. It should be kept in mind that the results of the thrombophilia panel analysis may change after the injection of radiopaque substances.

« Previous
Graphical Abstract

[1]
Rosendaal, F.R. Venous thrombosis: a multicausal disease. Lancet, 1999, 353(9159), 1167-1173.
[http://dx.doi.org/10.1016/S0140-6736(98)10266-0] [PMID: 10209995]
[2]
Buchholz, T.; Thaler, C.J. Inherited thrombophilia: impact on human reproduction. Am. J. Reprod. Immunol., 2003, 50(1), 20-32.
[http://dx.doi.org/10.1034/j.1600-0897.2003.00049.x] [PMID: 14506925]
[3]
Tascanov, M.B.; Gönel, A. How do contrast agents affect cardiac markers and coagulation tests? experimental study. Comb. Chem. High Throughput Screen., 2019, 22(5), 355-360.
[http://dx.doi.org/10.2174/1386207322666190603170438] [PMID: 31161978]
[4]
Gönel, A.; Tascanov, M.B.; Bayraktar, N.; Koyuncu, I.; Agan, V.; Enes, M.; Guzelcicek, A. In Vitro demonstration of drug-reagent interactions among commonly used parenteral drugs in cardiology. Cardiovasc. Hematol. Agents Med. Chem., 2021, 19(1), 43-49.
[http://dx.doi.org/10.2174/1871525718666200226115235] [PMID: 32101135]
[5]
Emerson, J.F.; Lai, K.K.Y. Endogenous antibody interferences in immunoassays. Lab. Med., 2013, 44(1), 69-73.
[http://dx.doi.org/10.1309/LMMURCFQHKSB5YEC]
[6]
Beato-Víbora, P.I.; Alejo-González, S. Avoiding misdiagnosis due to antibody interference with serum free thyroxin. Int. J. Endocrinol. Metab., 2016, 15(1), e37792.
[http://dx.doi.org/10.5812/ijem.37792] [PMID: 28835757]
[7]
Kuzmanovska, S.; Vaskova, O. Interference in thyroid function immunoassays: clinical consequences. Maced. pharm. bull., 2020, 66(1), 73-78.
[8]
Kwok, J.S.S.; Chan, I.H.S.; Chan, M.H.M. Biotin interference on TSH and free thyroid hormone measurement. Pathology, 2012, 44(3), 278-280.
[http://dx.doi.org/10.1097/PAT.0b013e3283514002] [PMID: 22437752]
[9]
Samarasinghe, S.; Meah, F.; Singh, V.; Basit, A.; Emanuele, N.; Emanuele, M.A.; Mazhari, A.; Holmes, E.W. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr. Pract., 2017, 23(8), 989-998.
[http://dx.doi.org/10.4158/EP171761.RA] [PMID: 28534685]
[10]
Piketty, M.L.; Prie, D.; Sedel, F.; Bernard, D.; Hercend, C.; Chanson, P.; Souberbielle, J.C. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin. Chem. Lab. Med., 2017, 55(6), 817-825.
[http://dx.doi.org/10.1515/cclm-2016-1183] [PMID: 28222020]
[11]
Trambas, C.; Lu, Z.; Yen, T.; Sikaris, K. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin–biotin immunoassays. Ann. Clin. Biochem., 2018, 55(2), 216-226.
[http://dx.doi.org/10.1177/0004563217707783] [PMID: 28406314]
[12]
Chun, K.Y. Biotin interference in diagnostic tests. Clin. Chem., 2017, 63(2), 619-620.
[http://dx.doi.org/10.1373/clinchem.2016.267286] [PMID: 28130485]
[13]
Oloko, A.; Talreja, H.; Davis, A.; McCormick, B.; Clark, E.; Akbari, A.; Kong, J.; Hiremath, S. Does iodinated contrast affect residual renal function in dialysis patients? A systematic review and meta-analysis. Nephron J., 2020, 144(4), 176-184.
[http://dx.doi.org/10.1159/000505576] [PMID: 32155642]
[14]
Gönel, A.; Koyuncu, I. False immunosuppressant measurement by LC-MS/MS method due to radiopaque agents. Comb. Chem. High Throughput Screen., 2019, 22(2), 129-134.
[http://dx.doi.org/10.2174/1386207322666190418125307] [PMID: 31038053]
[15]
Arranz-Peña, M.L.; González-Sagrado, M.; Olmos-Linares, A.M.; Fernández-García, N.; Martín-Gil, F.J. Interference of iodinated contrast media in serum capillary zone electrophoresis. Clin. Chem., 2000, 46(5), 736-737.
[http://dx.doi.org/10.1093/clinchem/46.5.736] [PMID: 10794768]
[16]
Lippi, G.; Daves, M.; Mattiuzzi, C. Interference of medical contrast media on laboratory testing. Biochem. Med. (Zagreb), 2014, 24(1), 80-88.
[http://dx.doi.org/10.11613/BM.2014.010] [PMID: 24627717]
[17]
Homberger, A.; Linnebank, M.; Winter, C.; Willenbring, H.; Marquardt, T.; Harms, E.; Koch, H.G. Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur. J. Hum. Genet., 2000, 8(9), 725-729.
[http://dx.doi.org/10.1038/sj.ejhg.5200522] [PMID: 10980581]
[18]
Peng, F.; Labelle, L.; Rainey, B.J.; Tsongalis, G. Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in US Caucasian and Hispanic American populations. Int. J. Mol. Med., 2001, 8(5), 509-511.
[http://dx.doi.org/10.3892/ijmm.8.5.509] [PMID: 11605019]
[19]
Demuth, K.; Moatti, N.; Hanon, O.; Benoit, M.O.; Safar, M.; Girerd, X. Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults. Arterioscler. Thromb. Vasc. Biol., 1998, 18(12), 1838-1843.
[http://dx.doi.org/10.1161/01.ATV.18.12.1838] [PMID: 9848874]
[20]
Otnes, S.; Fogh-Andersen, N.; Rømsing, J.; Thomsen, H.S. Analytical interference by contrast agents in biochemical assays. Contrast Media Mol. Imaging, 2017, 2017, 1-8.
[http://dx.doi.org/10.1155/2017/1323802] [PMID: 29097910]
[21]
Maddox, T.G. Adverse reactions to contrast material: recognition, prevention, and treatment. Am. Fam. Physician, 2002, 66(7), 1229-1234.
[PMID: 12387435]
[22]
Brinker, J. What every cardiologist should know about intravascular contrast. Rev. Cardiovasc. Med., 2003, 4(S5)(Suppl. 5), S19-S27.
[PMID: 14668706]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy